China-Taiwan Simultaneous Drug Applications Filed By TaiGen, Medigen
This article was originally published in PharmAsia News
Executive Summary
A China and Taiwan cooperative effort has received its first application, from TaiGen Biotechnology and Medigen Biotechnology investment firms for new-drug certification.